Directions for Use:
CogniCaps for Small Dogs: 60 Capsules
For dogs under 30 pounds, give one (1) capsule in the morning and one (1) capsule in the evening.
CogniCaps for Medium and Large Dogs: 120 Capsules
For dogs 30-60 pounds give one (1) capsule in the morning and two (2) capsules in the evening.
For dogs over 60 pounds give two (2) capsules in the morning and two (2) capsules in the evening.
The logic behind CogniCaps
Because there are so many individual dietary supplements that have shown efficacy in treating cognitive decline, veterinarians and their clients are often faced with the prospect of prescribing multiple separate supplements to produce a positive clinical response. In short, it often seems that there are too many potentially beneficial supplements to fit into one patient. It is also common practice to separate treatments for CCD into the categories of western and eastern medicine. Again, this conceptualization leads to the necessity of prescribing multiple supplements-both western (conventional) and eastern (non-conventional, holistic, etc.). Although pet owners often will administer multiple supplements to their senior dogs, it can be challenging. Also, it is unlikely that the average pet owner will administer multiple supplements to an asymptomatic middle-aged dog for preventive purposes. CogniCaps is a truly integrative supplement, combining a mixture of both western and eastern treatments in one small capsule.
How common is CCD?
According to Dr. Curtis Dewey, a veterinary neurologist with extensive knowledge on this subject, estimates of the prevalence of CCD generally vary between 14% and 35% of the pet dog population, in dogs 11-12 years old 28% and in dogs 15-16 years old 68%; however, he notes that those percentages are likely an under estimation of how common the disorder is. As with people with AD, the prevalence of CCD increases dramatically with age. Dogs may show evidence of brain changes as early as 6 years of age. Furthermore, many dogs with mild impairment will progress to moderate impairment and those with moderate disease often progress to severe impairment.
Is CCD treatable?
Fortunately, dogs with CCD are less likely to develop such severe impairment as occurs in people with AD. Affected dogs typically respond well to medical intervention, especially if instituted early in the disease process. There is also evidence in both AD and CCD that preventive measures such as dietary changes and environmental enrichment can both delay the onset and slow the progression of cognitive decline. This information suggests that simple preventive measures against CCD including dietary supplements as provided in CogniCaps, a proprietary formula developed by Dr. Dewey in conjunction with Dr. Fossum’s Pet Care, may be generally advisable in pet dogs as they near middle age.
Ingredients: Curcumin: 136mg, Zinc: 91mg, S-adenosylmethionine (SAMe): 68 mg, Salvia: 61mg, BioCog* (reg. pending): 60mg, Vitamin E: 32mg, Polygala: 30mg, Phosphatidylserine: 23mg, Coenzyme Q10: 5mg.
Inactive Ingredients: Soy, Cornstarch, Maltodextrin
Warning: Not for human consumption!
Keep out of the reach of children and animals. In case of accidental overdose, contact a health professional immediately.
Cautions: If animal’s condition worsens or does not improve, stop product administration and consult your veterinarian.
Safe use in pregnant animals or animals intended for breeding has not been proven.
Administer during or after the animal has eaten to reduce incidence of gastrointestinal upset.